Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease
Summary
- For patients with multiple PI-associated metabolic toxicities, substitution of the PI by an NNRTI or integrase inhibitor may be justified, assuming the switch would not result in loss of virologic control (Table 10)[Martínez 2000]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content